AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2018
Feb 13, 2018
29745_dirs_2018-02-13_4a91c248-8d5a-4712-8985-7484cbd00e8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-02-09
Reporting Person: Lundberg Jan M (EVP,Science&Tech and Pres. LRL)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-09 | Restricted Stock Unit | $ | A | 7871 | Acquired | 2021-02-09 | Common Stock (7871.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 198126 | Direct |
| Common Stock | 1086 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29